Bellevue Group »

Palvella Therapeutics Inc Ne shares owned by Bellevue Group

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Bellevue Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $24M 155k 152.82

More positions owned by Bellevue Group

Amgen (AMGN)
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Gilead Sciences (GILD)
Revolution Medicines (RVMD)
Oruka Therapeutics (ORKA)
Insmed Com Par $.01 (INSM)
Scholar Rock Hldg Corp (SRRK)
Nuvalent Inc-a (NUVL)
Miragen Therapeutics (VRDN)
Relay Therapeutics (RLAY)
Vaxcyte (PCVX)
United Therapeutics Corporation (UTHR)
Intuitive Surgical Com New (ISRG)
Regeneron Pharmaceuticals (REGN)

View all positions for Bellevue Group

Top funds holding Palvella Therapeutics Inc Ne

Suvretta Capital Management
Jennison Associates
BlackRock
Frazier Life Sciences Management
First Light Asset Management
BVF
Vanguard Capital Management
Frontier Capital Management
State Street Corporation
Federated Investors
T. Rowe Price Associates
OrbiMed Advisors
Woodline Partners
Geode Capital Management
Siren

View all funds holding Palvella Therapeutics Inc Ne